Small molecules as a source for acute kidney injury therapy

YL Feng, Y Yang, H Chen - Pharmacology & Therapeutics, 2022 - Elsevier
Acute kidney injury (AKI) is a sudden loss of kidney function that causes a rise in serum
creatinine and a decrease in urine output, which leads to high morbidity and mortality …

Nicorandil reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention–systematic review and meta-analysis of …

R Pranata, R Vania, AA Alkatiri, D Firman… - Cardiovascular …, 2020 - Elsevier
Background Contrast-induced nephropathy (CIN) is associated with increased mortality and
morbidity in patients undergoing coronary angiography (CAG) and percutaneous coronary …

Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency

H Fu, J Zhang, H Zhang, P Zhang, X Fu, Z Zeng… - …, 2021 - journals.sagepub.com
Background: Contrast-induced nephropathy (CIN) has become a common cause of hospital-
acquired acute kidney injury in elderly patients. Trimetazidine (TMZ) is a type of anti …

Pharmacologic Prophylaxis of Contrast-Induced Nephropathy.

A Toso, M Leoncini, M Maioli… - Interventional Cardiology …, 2020 - europepmc.org
Different pharmacologic agents have been tested in the effort to prevent contrast-induced
acute kidney injury (AKI) in the last two decades. To date, however, no individual drug has …

[HTML][HTML] Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: a network meta-analysis

Z Mei, S Luo, P Chen, Q Zhang, L Zhou, C Zhu, H Zhu… - PeerJ, 2022 - peerj.com
This study aimed to conduct a network meta-analysis (NMA) to compare the efficacy of brain
natriuretic peptide (BNP) vs nicorandil for preventing contrast-induced nephropathy (CIN) …

Cardioprotective and anti-anginal efficacy of Nicorandil: A Comprehensive Review

H Goel, M Carey, A Elshaikh, M Krinock… - Journal of …, 2022 - journals.lww.com
Angina pectoris remains a significant burden despite advances in medical therapy and
coronary revascularization. Many patients (up to 30%) with angina have normal coronary …

[PDF][PDF] Use of Renal Protective Agents to Prevent Contrast Induced Nephropathy in Renal Failure Patients: A Systematic Review

B Korrapati, T Reddi… - J Med Imaging …, 2022 - medimagingcasereports.com
Use of Renal Protective Agents to Prevent Contrast Induced Nephropathy in Renal Failure
Patients: A Systematic Review Page 1 51 Korrapati et al. Use of Renal Protective Agents to …

[HTML][HTML] Contrast Media Toxicity and Its Prevention

C Sessa, L Zanoli, G Noto… - Giornale Italiano …, 2023 - giornaleitalianodinefrologia.it
Intravenous iodinated contrast media are commonly used in clinical practice, ranging from
medical imaging to interventional radiology (IR) procedures and endovascular interventions …

[HTML][HTML] La tossicità da mezzo di contrasto iodato e la sua prevenzione

C Sessa, L Zanoli, G Noto, I Alessandrello, D Galeano… - giornaleitalianodinefrologia.it
Il mezzo di contrasto iodato viene ampiamente usato nella pratica clinica, dalla diagnostica
per immagini alle procedure radiointerventistiche ed endovascolari. Il paziente nefropatico …

[HTML][HTML] Protected: Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?

C Summaria, F Iorio, R Greco, F Leone, P Gigliotti… - giornaleitalianodinefrologia.it
Abstract Chronic Kidney Disease (CKD) is a clinical condition characterized by the
progressive loss of kidney function. 10% of the world's population is affected by this …